Alex MacKenzie

The hippocampal neurons of neuronal apoptosis inhibitory protein 1 (NAIP1)-deleted mice display increased vulnerability to kainic acid-induced injury.

The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7.

Distinct expression of neuronal apoptosis inhibitory protein (NAIP) during murine development.

Estrogen suppresses uterine epithelial apoptosis by inducing birc1 expression.

CHRIMCY: A proposed institute for research on reproduction, development, and mother, child and youth health.

Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway.

A generalizable pre-clinical research approach for orphan disease therapy.

Specific combination of compound heterozygous mutations in 17β-hydroxysteroid dehydrogenase type 4 (HSD17B4) defines a new subtype of D-bifunctional protein deficiency.

VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models.

DNM1L-related mitochondrial fission defect presenting as refractory epilepsy.

The Search for Pompe Patients in Canada: Assessing Feasibility of a National Disease Registry to Facilitate Research.

Human Growth Hormone Increases SMN Expression and Survival in Severe Spinal Muscular Atrophy Mouse Model.

Neuronal apoptosis inhibitory protein (NAIP) localizes to the cytokinetic machinery during cell division.

Pyridoxine-Dependent Epilepsy in Zebrafish Caused by Aldh7a1 Deficiency.

Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys.

Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization.

Transcriptomic RNAseq drug screen in cerebrocortical cultures; towards novel neurogenetic disease therapies.